Adapted physical activity program for children and teenagers with Osteogenesis Imperfecta

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research evaluates the impact of a 6-month adapted physical activity program on the endurance capacities of children and adolescents diagnosed with Osteogenesis Imperfecta. The study focuses on improving maximum oxygen consumption (VO2 peak) to address chronic fatigue and decreased physical endurance commonly experienced by these patients. By engaging in tailored physical activities, the program aims to enhance muscle function and overall quality of life for participants. The study is conducted at University Hospital in Toulouse and CHU Montpellier.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed Osteogenesis Imperfecta
* Informed and written consent signed by at least one of the two holders of parental authority
* Patient affiliated to a social security scheme or equivalent

Exclusion Criteria:

* Non-walking children (unable to perform the effort test)
* Pregnant or breastfeeding
* Participation in other interventional research

Where it's running

• CHU Toulouse
  Toulouse, France Recruiting
• CHU Montpellier Hôpital Arnaud de Villeneuve
  Montpellier, France Not yet recruiting

Study contacts

• Principal investigator: Thomas EDOUARD, MD — University Hospital, Toulouse
• Study coordinator: Thomas EDOUARD, MD
• Email: edouard.t@chu-toulouse.fr
• Phone: 05 61 77 61 10

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using REMS ultrasound to check bone density in children and teens with conditions that lower bone strength

  This project will test whether REMS, a radiation-free ultrasound method, can measure bone mineral density in children and adolescents aged 5–18 who have conditions that weaken their bones.

  Recruiting Meyer Children's Hospital IRCCS · Florence, Tuscany · NCT07412782

• Pediatric safety follow-up after romosozumab treatment for osteogenesis imperfecta

  This follow-up tests the safety of romosozumab in children and adolescents with osteogenesis imperfecta who previously received romosozumab in an earlier trial.

  Recruiting at 4 sites Phase 3 Amgen · Indianapolis, Indiana and 3 other locations · NCT07366086

• Heart structure and function in children and adults with Osteogenesis Imperfecta

  This project will follow children and adults with Osteogenesis Imperfecta to see how their heart structure and function change over a five-year period.

  Recruiting Istituto Ortopedico Rizzoli · Bologna, Emilia-Romagna · NCT07287241

• Evaluating hearing and balance in children and young adults with Osteogenesis Imperfecta

  This study is testing how Osteogenesis Imperfecta affects hearing and balance in kids and young adults aged 12 to 20 to better understand the condition's impact.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT05419960

• Effects of bisphosphonates on hearing loss in osteogenesis imperfecta

  This study is testing if a medication called bisphosphonates can help adults with Osteogenesis Imperfecta type I who have hearing loss.

  Recruiting Phase 4 Hospital for Special Surgery, New York · New York, New York · NCT04152551

• Registry for Osteogenesis Imperfecta

  This study is creating a registry to gather information from people with Osteogenesis Imperfecta to better understand the condition and improve how it's managed and treated.

  Recruiting Istituto Ortopedico Rizzoli · Bologna, Emilia-Romagna · NCT04115774

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.